Latest Administration News

Buru Energy pushes forward with its Rafael Gas Project development, securing A$5.3 million in funding and progressing environmental approvals while navigating executive leadership changes.

The Takeovers Panel has received an application alleging undisclosed associations and possible breaches of takeover laws following a massive off-market transfer of Adslot shares valued at $723,870.

Ceretas Limited is raising $8 million through an IPO to fund clinical trials and development of its novel therapeutic ultrasound device targeting Alzheimer’s disease symptoms.

Triangle Energy (ASX:TEG) and its key subsidiaries have appointed a voluntary administrator amid financial pressures linked to offshore decommissioning obligations. The move follows similar steps by related operators and signals ongoing regulatory and creditor negotiations ahead.

Hillgrove Resources boosted copper production and cash flow in the June quarter, hitting a 1.8Mtpa run rate at Kanmantoo and securing approval for the Emily Star underground development.

AFT Pharmaceuticals has received tentative US FDA approval for its Scomara cream to treat Facial Angiofibromas in Tuberous Sclerosis, but US commercialisation is postponed until 2029 due to orphan drug exclusivity. The approval bolsters regulatory prospects in other key markets where AFT anticipates competitive advantages.

AFT Pharmaceuticals secures tentative FDA approval for Scomara cream to treat rare facial tumours but faces a US launch delay due to orphan drug exclusivity. The approval bolsters prospects in other markets where AFT expects competitive advantages.

AdNeo Limited achieved a record positive operating cash flow of $451k in Q4 FY26 and secured significant customer contracts, setting the stage for disciplined growth in FY27.

HUB24 delivered a standout FY26 with record net inflows of $18.9 billion, a 20% rise excluding large migrations, and boosted total Funds Under Administration to $164.3 billion. The platform’s adviser base grew 11%, while new product launches and AI-driven tools expanded its market footprint.

Hancock Prospecting's Hanrine subsidiary has fast-tracked its earn-in to a majority 51% stake in Titan Minerals' Linderos Copper Project in Ecuador, backed by extensive porphyry copper intersections from recent drilling.

Telix Pharmaceuticals reported a 21% year-on-year revenue jump to US$247 million in Q2 2026, buoyed by strong Precision Medicine sales and a new Regeneron partnership. The company also secured FDA alignment on a pivotal prostate cancer trial and expanded its manufacturing footprint.

Almonty Industries will delist from the Toronto Stock Exchange by July 31, 2026, focusing its trading exclusively on Nasdaq to streamline costs and align with where most activity occurs.